Latest News Archive
Please select Category, Year, and then Month to display items
24 July 2024
|
Story Lacea Loader
The University of the Free State (UFS) is co-hosting the Global Social Innovation Indaba together with Social Innovation Exchange (SIX) on its Bloemfontein Campus from 30 September to 2 October 2024. This event brings together people from different sectors all over the world to discuss how to accelerate and support people-powered
change and create a better society for generations to come.
The UFS is excited to collaborate with SIX, as its vision and values overlap. During this three-day indaba, aspects such as – what it takes to build accountable, inclusive, and participatory institutions, specifically the future role of universities in South Africa – will be discussed. Themes to be explored include young people as drivers of change, post-industrial transitions and community resilience, the role of art, social change and bridging divides, and systemic approaches to dealing with unemployment.
Some of the speakers and participants in the programme include Carla Duprat from ICE (Brazil); Cheryl Jacob from ESquared Investments (South Africa); François Bonnici from the Schwab Foundation for Social Entrepreneurship (Switzerland); Sir Geoff Mulgan from the University College London (UCL) in the United Kingdom; and Dr Narissa Ramdhani from the Ifa Lethu Foundation (South Africa).
The UFS will also use the opportunity to showcase its campus and offerings to attendees, focusing on its transformation story and some of the interdisciplinary forward-thinking programmes. Guests will also be treated to true South African hospitality, laying the foundation for strong relationships and collaboration.
SIX believes in the transformative power of people working together. Exchanges based on mutual value and reciprocity are the missing link in tackling the world’s problems. As a friendly, expert entry point to global social innovation, their work connects organisations, sectors, communities, and nations to build capabilities and create opportunities for collaboration.
Haemophilia home infusion workshop
2017-12-17
Parents receive training for homecare of their children with haemophilia.
Photo Supplied
Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.”
Clinical skills to empower parents and communities
There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.
The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.
A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.